Clean Yield Group - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.

Quarter-by-quarter ownership
Clean Yield Group ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$9,085,000
-4.5%
208,708
-4.4%
3.76%
+11.8%
Q1 2022$9,509,000
-0.1%
218,288
+1.1%
3.36%
+10.4%
Q4 2021$9,519,000
+16.6%
215,858
+1.1%
3.04%
+13.6%
Q3 2021$8,162,000
-1.0%
213,598
+3.1%
2.68%
-4.5%
Q2 2021$8,248,000
+25.2%
207,123
+12.2%
2.80%
+13.1%
Q1 2021$6,587,000
+11456.1%
184,575
+11885.4%
2.48%
+12290.0%
Q4 2020$57,000
-1.7%
1,5400.0%0.02%
-16.7%
Q3 2020$58,000
-7.9%
1,5400.0%0.02%
-11.1%
Q2 2020$63,000
+8.6%
1,5400.0%0.03%
-3.6%
Q1 2020$58,000
-47.7%
1,540
-34.7%
0.03%
-20.0%
Q4 2019$111,000
-22.4%
2,360
-29.8%
0.04%
-25.5%
Q3 2019$143,000
+6.7%
3,3600.0%0.05%
-2.1%
Q2 2019$134,000
-4.3%
3,3600.0%0.05%
-15.8%
Q1 2019$140,000
+55.6%
3,360
+42.4%
0.06%
+46.2%
Q4 2018$90,000
-37.9%
2,360
-31.6%
0.04%
-36.1%
Q1 2017$145,0000.0%3,450
+2.7%
0.06%
-3.2%
Q3 2016$145,000
+42.2%
3,360
+42.4%
0.06%
+43.2%
Q2 2016$102,000
-28.7%
2,360
-29.8%
0.04%
-31.2%
Q1 2016$143,000
-14.9%
3,360
-7.9%
0.06%
-11.1%
Q1 2015$168,000
-25.0%
3,650
-30.4%
0.07%
-28.7%
Q4 2014$224,000
-7.1%
5,2430.0%0.10%
-12.9%
Q3 2014$241,000
-13.9%
5,2430.0%0.12%
-15.9%
Q2 2014$280,0000.0%5,2430.0%0.14%
-4.8%
Q1 2014$280,0000.0%5,2430.0%0.14%
-3.3%
Q4 2013$280,000
+6.5%
5,2430.0%0.15%
+5.6%
Q3 2013$263,000
+0.4%
5,2430.0%0.14%
-5.3%
Q2 2013$262,0005,2430.15%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q4 2013
NameSharesValueWeighting ↓
KAHN BROTHERS GROUP INC 1,282,289$46,483,4037.25%
Columbia Asset Management 9,960$3610.08%
PARK CIRCLE Co 800$29,0000.03%
PARADIGM ASSET MANAGEMENT CO LLC 1,800$65,2500.02%
Byrne Asset Management LLC 56$2,0000.00%
Retirement Group, LLC 40$1,4500.00%
Bartlett & Co. LLC 240$90.00%
HUNTINGTON NATIONAL BANK 1$400.00%
View complete list of GLAXOSMITHKLINE PLC shareholders